C5 Variant rs10985126 is Associated with Mortality in Patients with Symptomatic Coronary Artery Disease

BACKGROUND: Complement component 5a (C5a) is a highly potent anaphylatoxin with a variety of pro-inflammatory effects. C5a contributes to progression of atherosclerosis and inhibition of the receptor (C5aR) might offer a therapeutic strategy in this regard. Single nucleotide polymorphisms (SNPs) of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pharmgenomics Pers Med
Autors principals: Henes, Jessica Kristin, Groga-Bada, Patrick, Schaeffeler, Elke, Winter, Stefan, Hack, Luis, Zdanyte, Monika, Mueller, Karin, Droppa, Michal, Stimpfle, Fabian, Gawaz, Meinrad, Langer, Harald, Schwab, Matthias, Geisler, Tobias, Rath, Dominik
Format: Artigo
Idioma:Inglês
Publicat: Dove 2021
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8312322/
https://ncbi.nlm.nih.gov/pubmed/34321906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S307827
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars